FIGURE 4 4.2 Enhanced CDT and ferroptotic therapy In the past few decades, CDT has become an emerging invasive TME-responsive cancer treatment based on Fenton or a Fenton-like reaction, which uses transition metal (including Fe, Mn, and Cu) to convert endogenous abundant H 2 O 2 into highly toxic OH, contributing to irreversible cellular damage
Start there
Hufige Nebenwirkungen (bei weniger als 10% der Anwender): Morgendliche Benommenheit in den ersten Anwendungstagen Leichte Kopfschmerzen bei Dosisnderungen Vernderungen der Traumaktivitt Lokale Reaktionen an der Injektionsstelle Seltene Nebenwirkungen knnen Stimmungsvernderungen oder vorbergehende Mdigkeit am Tag umfassen
Wrinkles, fine lines and loss of firmness
or 200 mg/kg b.w., s.c., in pre-(24 hours or 1 hour before alloxan application), co- and post- (48 hours following alloxan application) treatments
This is not just a technical term